Ben Sessa

http://www.drsessa.com/

Ben Sessa is an English psychiatrist, researcher, and author. Dr. Sessa is also the Chief Medical Officer of Awakn Life Sciences, and has been a part of scientific and clinical studies administering LSD, psilocybin, ketamine, MDMA and DMT to patients and volunteers.

Dr. Ben Sessa Gets Suspended From Practicing Psychiatry for Sexual Misconduct

Leading psychedelics researcher Dr. Ben Sessa has been officially banned from practicing medicine in the UK for a year after engaging in an intimate relationship...

The State of Psychedelic Reform in the UK and EU

The push for psychedelic legal reform in the US has gained some serious wins over the last few years, with states such as Colorado and...

First Study to Look at Candy Flipping Suggests Potential for Psychedelic Therapy

Popularized in the late 90s rave scene, mixing MDMA and LSD, also known as candy flipping, remains hugely popular among psychonauts and partygoers today. Described...

EP 27 DR Ben Sessa

In today’s podcast, I did a live event with Dr. Ben Sessa. at Luna Palace in Leederville. Ben was in town to help with various...

Awakn Loses Psychedeclics Chief, Gains New Treatment Clinics

Canada-based biotech firm Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) has lost its head of psychedelic medicine, but due to the loss,...

Awakn Loses Psychedeclics Chief, Gains New Treatment Clinics - Green Market Report

Dr. Ben Sessa resigned his position as head of psychedelic medicine at the company and is transferring his 49% ownership in Awakn Bristol Limited.

The Complete 2022 Stock Market Analysis (PRO REPORT)

January-March The past few months haven’t been kind to psychedelic investors and January was no exception. In 2021, we saw three companies IPO at a...

Awakn Makes Its Case To Investors

British psychiatrist Ben Sessa believes fervently in psychedelic medicines. They are “likely to change the whole paradigm of psychiatry,” says Sessa, the chief medical officer...

MDMA-Assisted Psychotherapy for Alcohol Use Disorder with Dr. Ben Sessa

In this episode of the Psychedelic Medicine Podcast, Dr. Ben Sessa joins to share results of his investigation into MDMA-assisted psychotherapy for alcohol use disorder....

Psychedelic Stock Market Update July 2022

July was a positive month for psychedelic investors with the market showing signs of price growth. Individual stocks such as Compass Pathways (CMPS), Relmada Therapeutics...

Awakn's Ben Sessa Tells All About MDMA and Netflix Docuseries - The Dales Report

We've invited Dr. Sessa to talk in depth about MDMA molecules following his appearance on the Netflix docuseries about psychedelics.

CATALYST Summit 2021: Psychedelic Medicine Global Conference

May 07, 2021

Last updated: Apr 16, 2021

Request Deletion